TESTBANK f
Tietz Fundamentals Of
f f
CLINICAL CHEMISTRY AND
f f
f MOLECULAR DIAGNOSTICS f
7th Edition By Carl A. Burtis
f f f f f
TESTBANK f
,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 7th Edition Test Bank
f f f f f f f f
f
f f
Table of contents:
f f
I. Principles Of Laboratory Medicine
f f f f
Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
f f f f f f f f
Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
f f f f f f f f f f f
Chapter 3. Clinical Evaluation of Methods
f f f f f
Chapter 4. Evidence-Based Laboratory Medicine
f f f f
Chapter 5. Establishment and Use of Reference Values
f f f f f f f
Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
f f f f f f f f
Chapter 7. Quality Management
f f f
II. Analytical Techniques And Instrumentation
f f f f
Chapter 8. Principles of Basic Techniques and Laboratory Safety
f f f f f f f f
Chapter 9. Optical Techniques
f f f
Chapter 10. Electrochemistry and Chemical Sensors
f f f f f
Chapter 11. Electrophoresis
f f
Chapter 12. Chromatography
f f
Chapter 13. Mass Spectrometry
f f f
Chapter 14. Enzyme and Rate Analyses
f f f f f
Chapter 15. Immunochemical Techniques
f f f
Chapter 16 Automationf f
Chapter 17. Point-of-Care Instrumentation
f f f
III. Analytesf
Chapter 18. Amino Acids, Peptides, and Proteins
f f f f f f
Chapter 19. Serum Enzymes
f f f
Chapter 20. Tumor Markers and Cancer Genes
f f f f f f
Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
f f f f f f f f f f f
Chapter 22. Carbohydrates
f f
Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
f f f f f f f f f
Chapter 24. Electrolytes and Blood Gases
f f f f f
Chapter 25. Hormones f f
Chapter 26. Catecholamines and Serotonin
f f f f
Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
f f f f f f
Chapter 28. Hemoglobin, Iron, and Bilirubin
f f f f f
Chapter 29. Porphyrins and Porphyrias
f f f f
Chapter 30. Therapeutic Drugs and Their Management
f f f f f f
Chapter 31. Clinical Toxicology
f f f
Chapter 32. Toxic Metals
f f f
IV. Pathophysiology
f
Chapter 33. Diabetes f f
,Chapter 34. Cardiovascular Disease
f f f
Chapter 35. Kidney Disease
f f f
Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
f f f f f f f f f f
Chapter 37. Liver Disease
f f f
Chapter 38. Gastrointestinal and Pancreatic Diseases
f f f f f
Chapter 39. Disorders of Bone and Mineral Metabolism
f f f f f f f
Chapter 40. Disorders of the Pituitary Gland
f f f f f f
Chapter 41. Disorders of the Adrenal Cortex
f f f f f f
Chapter 42. Thyroid Disorders
f f f
Chapter 43. Reproduction-Related Disorders
f f f
Chapter 44. Pregnancy and Prenatal Testing
f f f f f
Chapter 45. Newborn Screening and Inborn Errors of Metabolism
f f f f f f f f
Chapter 46. Pharmacogenetics
f f
V. Molecular Diagnostics
f f
Chapter 47. Principles of Molecular Biology
f f f f f
Chapter 48. Nucleic Acid Techniques and Applications
f f f f f f
Chapter 49. Genomes and Nucleic Acid Alterations
f f f f f f
, Tietz Fundamentals of Clinical Chemistry and MolecularDiagnostics, 7e Burtis Test Bank
f f f f f f f f f f
Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory MedicineTest Bank
f f f f f f f f f
MULTIPLE CHOICE f
1. An individual working in a clinical chemistry laboratory is married to a sales representative
f f f f f f f f f f f f f
who works for a company that sells chemistry laboratory supplies. When the laboratory
f f f f f f f f f f f f f
manager requests a list of needed supplies, cost of supplies, and vendors, this individual only
f f f f f f f f f f f f f f f
recommends the spouse’s company as the vendor. This is considered to be a(n):
f f f f f f f f f f f f f
a. accounting issue. f
b. possible conflict of interest. f f f
c. maintenance of confidentiality issue. f f f
d. problem with resource allocation. f f f
ANS: B f
Concern has been raised over the interrelationships between practitioners in the medical field and
f f f f f f f f f f f f f
commercial suppliers of drugs, devices, equipment, etc., to the medical profession.
f f f f f f f f f f f
Similarly, relationships have been scrutinized between clinical laboratorians and manufacturers
f f f f f f f f f
and providers of diagnostic equipment and supplies. These concerns led the National Institutes
f f f f f f f f f f f f f
of Health (NIH) in 1995 to require official institutional review of financial disclosure by
f f f f f f f f f f f f f f
researchers and management of situations in which disclosure indicates potential conflicts of
f f f f f f f f f f f f
interest.
f
DIF: 1 REF: Page 4-5 f f f OBJ: 6 | 7 f f f
2. A patient visits her physician stating that her prescribed painkiller is not working to reduce
f f f f f f f f f f f f f f
the pain following her recent surgery. A friend of the patient claims that the same painkiller
f f f f f f f f f f f f f f f f
“worked wonders” to reduce her pain after the same surgery. The physician states that the
f f f f f f f f f f f f f f f
difference in the effect of the drug might be caused by
f f, which is studied in
f f f f f f f f f f f f f
pharmacogenetics.
f
a. epidemiology
b. an inherited disease f f
c. a conflict of interestf f f
d. a genetic variation in drug-metabolizing enzymes
f f f f f
ANS: D f
Pharmacogenetics is the study of the genetic variation of drug metabolism between f f f f f f f f f f f
individuals.
f
DIF: 1 REF: Page 3 f f f OBJ: 1 f
3. John works in a molecular diagnostics laboratory and receives a blood sample that has the
f f f f f f f f f f f f f f
name of a close friend printed on the bar-coded label. The genetic test that is ordered on the
f f f f f f f f f f f f f f f f f f
friend’s sample would provide diagnostic information about a disorder that has a poor
f f f f f f f f f f f f f
prognosis, and the test is usually performed by John. He asks a fellow employee to analyze
f f f f f f f f f f f f f f f f
the sample for him and not divulge the results. This ethical issue concerns:
f f f f f f f f f f f f f
a. confidentiality of patient genetic and medical information. f f f f f f
b. a conflict of interest.
f f f
c. resource allocation. f
d. diagnostic accuracy. f
Tietz Fundamentals Of
f f
CLINICAL CHEMISTRY AND
f f
f MOLECULAR DIAGNOSTICS f
7th Edition By Carl A. Burtis
f f f f f
TESTBANK f
,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 7th Edition Test Bank
f f f f f f f f
f
f f
Table of contents:
f f
I. Principles Of Laboratory Medicine
f f f f
Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
f f f f f f f f
Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
f f f f f f f f f f f
Chapter 3. Clinical Evaluation of Methods
f f f f f
Chapter 4. Evidence-Based Laboratory Medicine
f f f f
Chapter 5. Establishment and Use of Reference Values
f f f f f f f
Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
f f f f f f f f
Chapter 7. Quality Management
f f f
II. Analytical Techniques And Instrumentation
f f f f
Chapter 8. Principles of Basic Techniques and Laboratory Safety
f f f f f f f f
Chapter 9. Optical Techniques
f f f
Chapter 10. Electrochemistry and Chemical Sensors
f f f f f
Chapter 11. Electrophoresis
f f
Chapter 12. Chromatography
f f
Chapter 13. Mass Spectrometry
f f f
Chapter 14. Enzyme and Rate Analyses
f f f f f
Chapter 15. Immunochemical Techniques
f f f
Chapter 16 Automationf f
Chapter 17. Point-of-Care Instrumentation
f f f
III. Analytesf
Chapter 18. Amino Acids, Peptides, and Proteins
f f f f f f
Chapter 19. Serum Enzymes
f f f
Chapter 20. Tumor Markers and Cancer Genes
f f f f f f
Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
f f f f f f f f f f f
Chapter 22. Carbohydrates
f f
Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
f f f f f f f f f
Chapter 24. Electrolytes and Blood Gases
f f f f f
Chapter 25. Hormones f f
Chapter 26. Catecholamines and Serotonin
f f f f
Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
f f f f f f
Chapter 28. Hemoglobin, Iron, and Bilirubin
f f f f f
Chapter 29. Porphyrins and Porphyrias
f f f f
Chapter 30. Therapeutic Drugs and Their Management
f f f f f f
Chapter 31. Clinical Toxicology
f f f
Chapter 32. Toxic Metals
f f f
IV. Pathophysiology
f
Chapter 33. Diabetes f f
,Chapter 34. Cardiovascular Disease
f f f
Chapter 35. Kidney Disease
f f f
Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
f f f f f f f f f f
Chapter 37. Liver Disease
f f f
Chapter 38. Gastrointestinal and Pancreatic Diseases
f f f f f
Chapter 39. Disorders of Bone and Mineral Metabolism
f f f f f f f
Chapter 40. Disorders of the Pituitary Gland
f f f f f f
Chapter 41. Disorders of the Adrenal Cortex
f f f f f f
Chapter 42. Thyroid Disorders
f f f
Chapter 43. Reproduction-Related Disorders
f f f
Chapter 44. Pregnancy and Prenatal Testing
f f f f f
Chapter 45. Newborn Screening and Inborn Errors of Metabolism
f f f f f f f f
Chapter 46. Pharmacogenetics
f f
V. Molecular Diagnostics
f f
Chapter 47. Principles of Molecular Biology
f f f f f
Chapter 48. Nucleic Acid Techniques and Applications
f f f f f f
Chapter 49. Genomes and Nucleic Acid Alterations
f f f f f f
, Tietz Fundamentals of Clinical Chemistry and MolecularDiagnostics, 7e Burtis Test Bank
f f f f f f f f f f
Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory MedicineTest Bank
f f f f f f f f f
MULTIPLE CHOICE f
1. An individual working in a clinical chemistry laboratory is married to a sales representative
f f f f f f f f f f f f f
who works for a company that sells chemistry laboratory supplies. When the laboratory
f f f f f f f f f f f f f
manager requests a list of needed supplies, cost of supplies, and vendors, this individual only
f f f f f f f f f f f f f f f
recommends the spouse’s company as the vendor. This is considered to be a(n):
f f f f f f f f f f f f f
a. accounting issue. f
b. possible conflict of interest. f f f
c. maintenance of confidentiality issue. f f f
d. problem with resource allocation. f f f
ANS: B f
Concern has been raised over the interrelationships between practitioners in the medical field and
f f f f f f f f f f f f f
commercial suppliers of drugs, devices, equipment, etc., to the medical profession.
f f f f f f f f f f f
Similarly, relationships have been scrutinized between clinical laboratorians and manufacturers
f f f f f f f f f
and providers of diagnostic equipment and supplies. These concerns led the National Institutes
f f f f f f f f f f f f f
of Health (NIH) in 1995 to require official institutional review of financial disclosure by
f f f f f f f f f f f f f f
researchers and management of situations in which disclosure indicates potential conflicts of
f f f f f f f f f f f f
interest.
f
DIF: 1 REF: Page 4-5 f f f OBJ: 6 | 7 f f f
2. A patient visits her physician stating that her prescribed painkiller is not working to reduce
f f f f f f f f f f f f f f
the pain following her recent surgery. A friend of the patient claims that the same painkiller
f f f f f f f f f f f f f f f f
“worked wonders” to reduce her pain after the same surgery. The physician states that the
f f f f f f f f f f f f f f f
difference in the effect of the drug might be caused by
f f, which is studied in
f f f f f f f f f f f f f
pharmacogenetics.
f
a. epidemiology
b. an inherited disease f f
c. a conflict of interestf f f
d. a genetic variation in drug-metabolizing enzymes
f f f f f
ANS: D f
Pharmacogenetics is the study of the genetic variation of drug metabolism between f f f f f f f f f f f
individuals.
f
DIF: 1 REF: Page 3 f f f OBJ: 1 f
3. John works in a molecular diagnostics laboratory and receives a blood sample that has the
f f f f f f f f f f f f f f
name of a close friend printed on the bar-coded label. The genetic test that is ordered on the
f f f f f f f f f f f f f f f f f f
friend’s sample would provide diagnostic information about a disorder that has a poor
f f f f f f f f f f f f f
prognosis, and the test is usually performed by John. He asks a fellow employee to analyze
f f f f f f f f f f f f f f f f
the sample for him and not divulge the results. This ethical issue concerns:
f f f f f f f f f f f f f
a. confidentiality of patient genetic and medical information. f f f f f f
b. a conflict of interest.
f f f
c. resource allocation. f
d. diagnostic accuracy. f
